Will Gilead’s Run Come To An End This Quarter?
April 28, 2016 at 11:00 AM EDT
For Gilead Sciences, Inc., we calling for earnings per share $3.23 on $8.21 billion in revenue, 11 cents higher than Wall Street on the bottom and $130 million on the top.